RioCan 2Q FFO C$0.43/Shr; Net C$78.5M

---

Taseko Mines 2Q Loss/Shr C$0.02; Rev C$82.9M


Expected Major Events for Tuesday

06:00/JPN: Jul Preliminary Machine Tool Orders

10:00/FRA: Jun OECD Composite Leading Indicators

10:00/US: Jul NFIB Index of Small Business Optimism

12:30/US: 2Q Preliminary Productivity & Costs

12:55/US: 08/06 Johnson Redbook Retail Sales Index

14:00/US: Aug IBD/TIPP Economic Optimism Index

20:30/US: 08/05 API Weekly Statistical Bulletin

23:50/JPN: Jul Corporate Goods Price Index

All times in GMT. Powered by Onclusive and Dow Jones.


Expected Earnings for Tuesday

22nd Century Group Inc (XXII) is expected to report $-0.06 for 2Q.

908 Devices Inc (MASS) is expected to report for 2Q.

AFC Gamma Inc (AFCG) is expected to report for 2Q.

AdaptHealth Corp (AHCO) is expected to report for 2Q.

Amyris Inc (AMRS) is expected to report $-0.29 for 2Q.

Avanos Medical Inc (AVNS) is expected to report $0.30 for 2Q.

Axsome Therapeutics Inc (AXSM) is expected to report $-1.39 for 2Q.

Bausch Health Companies Inc (BHC,BHC.T) is expected to report $-0.14 for 2Q.

Broadwind Inc (BWEN) is expected to report $-0.11 for 2Q.

CEVA Inc (CEVA) is expected to report $-0.03 for 2Q.

CSI Compressco LP (CCLP) is expected to report for 2Q.

Capri Holdings Ltd (CPRI) is expected to report $1.36 for 1Q.

ChannelAdvisor (ECOM) is expected to report $0.03 for 2Q.

Clear Channel Outdoor Holdings Inc (CCO) is expected to report for 2Q.

Core Molding (CMT) is expected to report for 2Q.

Cronos Group Inc (CRON,CRON.T) is expected to report $-0.05 for 2Q.

Dine Brands Global (DIN) is expected to report $1.57 for 2Q.

Distribution Solutions Group Inc (DSGR) is expected to report $0.64 for 2Q.

Emerson Electric (EMR) is expected to report $1.05 for 3Q.

FTI Consulting (FCN) is expected to report $1.74 for 4Q.

Healthcare Realty Trust Inc (HR) is expected to report for 2Q.

Hilton Grand Vacations Inc (HGV) is expected to report $0.82 for 2Q.

Horizon Global Corp (HZN) is expected to report $-0.22 for 2Q.

Hyatt Hotels (H) is expected to report $-0.03 for 2Q.

IAA Inc (IAA) is expected to report for 2Q.

Infinity Pharmaceuticals (INFI) is expected to report $-0.14 for 2Q.

Ingredion Inc (INGR) is expected to report $1.95 for 2Q.

Ionis Pharmaceuticals Inc (IONS) is expected to report $-0.61 for 2Q.

Kymera Therapeutics Inc (KYMR) is expected to report for 2Q.

LB Foster Co (FSTR) is expected to report $0.18 for 2Q.

Louisiana-Pacific Corp (LPX) is expected to report $4.38 for 2Q.

Melco Resorts & Entertainment Ltd (MLCO) is expected to report $-0.41 for 2Q.

Norwegian Cruise Line Holdings (NCLH) is expected to report $-0.83 for 2Q.

Pennsylvania Real Estate Investment Trust (PEI) is expected to report for 2Q.

Ralph Lauren Corp (RL) is expected to report $1.76 for 1Q.

Reynolds Consumer Products Inc (REYN) is expected to report for 2Q.

Sun Country Airlines Holdings Inc (SNCY) is expected to report for 2Q.

Syros Pharmaceuticals Inc (SYRS) is expected to report $-0.38 for 2Q.

Tennant Co (TNC) is expected to report $0.73 for 2Q.

Warner Music Group Corp (WMG) is expected to report for 3Q.

Powered by Onclusive and Dow Jones.


ANALYST RATINGS ACTIONS

8X8 Raised to Buy From Neutral by B of A Securities

a.k.a. Brands Holding Cut to Market Perform From Outperform by Cowen & Co.

ACADIA Pharmaceuticals Cut to Neutral From Buy by Citigroup

Americold Realty Trust Cut to Sector Perform From Outperform by RBC Capital

Avalara Cut to Hold From Buy by Needham

Avalara Cut to Neutral From Overweight by Piper Sandler

Azek Cut to Neutral From Outperform by Wedbush

Ball Cut to Neutral From Overweight by JP Morgan

Bed Bath & Beyond Cut to Hold From Buy by Odeon Capital

BioCryst Pharmaceuticals Cut to Perform From Outperform by Oppenheimer

Biohaven Pharma Cut to Neutral From Outperform by Wedbush

Carvana Cut to Underweight From Neutral by JP Morgan

Casa Systems Cut to Market Perform From Outperform by Northland Capital Markets

Centrus Energy Raised to Buy From Neutral by Roth Capital

Coeur Mining Cut to Market Perform From Outperform by Noble Capital Markets

Collegium Pharmaceutical Cut to Neutral From Buy by HC Wainwright & Co.

Corteva Raised to Overweight From Neutral by JP Morgan

Elevation Oncology Cut to Neutral From Overweight by JP Morgan

First Solar Raised to Buy From Neutral by Guggenheim

First Solar Raised to Overweight From Neutral by JP Morgan

Global Blood Therapeutics Cut to Hold From Buy by Jefferies

Global Blood Therapeutics Cut to Hold From Buy by Stifel

Global Blood Therapeutics Cut to Neutral From Outperform by Wedbush

Global Blood Therapeutics Raised to Buy From Hold by Canaccord Genuity

Henry Schein Raised to Neutral From Sell by UBS

Innovative Indl Props Cut to Neutral From Buy by Compass Point

iRobot Raised to Neutral From Underweight by JP Morgan

Leslie's Cut to Market Perform From Outperform by Telsey Advisory Group

Main Street Capital Cut to Market Perform From Outperform by Raymond James

Monroe Capital Cut to Perform From Outperform by Oppenheimer

Nektar Therapeutics Cut to Underweight From Neutral by JP Morgan

Newtek Raised to Market Perform From Underperform by Raymond James

Nvidia Cut to Hold From Buy by Craig-Hallum

Orchid Island Capital Cut to Neutral From Buy by Ladenburg Thalmann

Park Hotels & Resorts Cut to Neutral From Outperform by SMBC Nikko

PowerFleet Raised to Outperform From Market Perform by Barrington Research

Rhythm Pharmaceuticals Raised to Buy From Neutral by Goldman Sachs

Rocket Cos. Cut to Underperform From Market Perform by Keefe, Bruyette & Woods

Roku Cut to Sell From Hold by Pivotal Research

TPI Composites Raised to Overweight From Neutral by JP Morgan

Warner Bros.Discovery Cut to Market Perform From Outperform by Barrington Research

Western Digital Cut to Hold From Buy by Benchmark

This article is a text version of a Wall Street Journal newsletter published earlier today.


(END) Dow Jones Newswires

08-09-22 0515ET